Company
Fusion Antibodies PLC
LON:FAB
Fusion is a Belfast based contract research organisation ("CRO") providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications. The Company's ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation
27 stories · page 1 of 2
Archive
Fusion Antibodies fired up by R&D deal with US biotech business
Under the terms of the deal the AIM listed company will provide its discovery and engineering services in relation to the research and development of several pre-determined projects.
Archive
Pendragon accelerates as it raises full year profit forecast
A look at the major movers on the London market on Thursday
Archive
Small Cap Movers: Good news, bad news week for AIM life sciences companies engaged in the battle to beat coronavirus
A look back at some of the more interesting stories from London's junior market this week
Archive
Small Cap movers: Gattaca shares suffer as it falls victim to Huawei contagion
A look back at some of the more interesting stories from the junior market over the past week
Investments and investor services
Mirror and Express newspapers owner Reach rises after increase in adjusted profits
A look at the day's major movers, including IOG, Diurnal, Audioboom, RTC, Baron Oil, United Oil & Gas, Reabold Resources, Andalas Energy, DeepMatter and Fusion Antibodies